Erratum to "Regulation of obesity and lipid disorders by herbal extracts from Morus alba, Melissa officinalis, and Artemisia capillaris in high fat diet-induced obese mice" [J. Ethnopharmacol. 115 (2008) 263-270 (DOI:10.1016/j.jep.2007.09.029);Regulation of obesity and lipid disorders by herbal extracts from Morus alba, Melissa officinalis, and Artemisia capillaris in high-fat diet-induced obese mice

Journal of Ethnopharmacology

Volumn 115, Issue 2, 2008, Pages 263-270

  Lee, Jinmi ^a   Chae, Kyungsil ^a   Ha, Juran ^a   Park, Byung Young ^b   Lee, Hee Suk ^b   Jeong, Sunhyo ^a   Kim, Min Young ^b   Yoon, Michung ^a  

^a Mokwon University   (South Korea)

^b AngioLab Inc   (South Korea)

Author keywords

Adiposity; Anti obesity plants; Lipid metabolism; Obesity; PPAR

Indexed keywords

1 DEOXYNOJIRIMYCIN; ARTEMISIA CAPILLARIS EXTRACT; ARTEMISIA CAPILLARIS EXTRACT PLUS MELISSA OFFICINALIS EXTRACT PLUS MORUS ALBA EXTRACT; ARTEMISIA IWAYOMOGI EXTRACT; CHOLESTEROL; FATTY ACID; LIPID; LUCIFERASE; MELISSA OFFICINALIS EXTRACT; MESSENGER RNA; MORUS ALBA EXTRACT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PLANT EXTRACT; ROSMARINIC ACID; SCOPARONE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTEMISIA CAPILLARIS; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA RESPONSIVE ELEMENT; FATTY ACID OXIDATION; GENE EXPRESSION; HYPERLIPIDEMIA; HYPOTHESIS; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIVER CELL; MALE; MEDICINAL PLANT; MELISSA OFFICINALIS; MORUS ALBA; MOUSE; NONHUMAN; OBESITY; PROTEIN EXPRESSION; REPORTER GENE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

ARTEMISIA CAPILLARIS; ARTEMISIA IWAYOMOGI; ASTERACEAE; LAMIACEAE; MELISSA OFFICINALIS; MORACEAE; MORUS ALBA; MUS;

EID: 37249030324     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.01.004     Document Type: Erratum

References (33)

1. Ayama T., Peters J.M., Iritani N., Nakajima T., Furihata K., Hashimoto T., and Gonzalez F.J. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα). The Journal of Biological Chemistry 273 (1998) 5678-5684
2. Bolkent S., Yanardag R., Karabulut-Bulan O., and Yesilyaprak B. Protective role of Melissa officinalis L. extract on liver of hyperlipidemic rats: a morphological and biochemical study. Journal of Ethnopharmacology 99 (2005) 391-398
3. Bourgeois F., Alexiu A., and Lemonnier D. Dietary-induced obesity: effect of dietary fats on adipose tissue cellularity in mice. The British Journal of Nutrition 49 (1983) 17-26
4. Carmona M.C., Louche K., Nibbelink M., Prunet B., Bross A., Desbazeille M., Dacquet C., Renard P., Casteilla L., and Pénicaud L. Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice. International Journal of Obesity (London) 29 (2005) 864-871
5. Chaput E., Saladin R., Silvestre M., and Edgar A.D. Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight. Biochemical and Biophysical Research Communications 271 (2000) 445-450
6. Chen J., and Li X. Hypolipidemic effect of flavonoids from mulberry leaves in triton WR-1339 induced hyperlipidemic mice. Asia Pacific Journal of Clinical Nutrition 16 (2007) 290-294
7. Costet P., Legendre C., More J., Edgar A., Galtier P., and Pineau T. Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis. The Journal of Biological Chemistry 273 (1998) 29577-29585
8. Das D.K., and Maulik N. Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Molecular Interventions 6 (2006) 36-47
9. Fruchart J.C., Brewer Jr. H.B., and Leitersdorf E. Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group. The American Journal of Cardiology 81 (1998) 912-917
10. Guerre-Millo M., Gervois P., Raspe E., Madsen L., Poulain P., Derudas B., Herbert J.M., Winegar D.A., Willson T.M., Fruchart J.C., Berge R.K., and Staels B. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. The Journal of Biological Chemistry 275 (2000) 16638-16642
11. Jeong S., and Yoon M. Inhibition of the actions of peroxisome proliferator-activated receptor alpha on obesity by estrogen. Obesity (Silver Spring) 15 (2007) 1430-1440
12. Jeong S., Kim M., Han M., Lee H., Ahn J., Kim M., Song Y.H., Shin C., Nam K.H., Kim T.W., Oh G.T., and Yoon M. Fenofibrate prevents obesity and hypertriglyceridemia in LDL receptor-null mice. Metabolism 53 (2004) 607-613
13. Jeong S., Han M., Lee H., Kim M., Nicol C.J., Kim B.H., Choi J.H., Oh G.T., and Yoon M. Effects of fenofibrate on high fat diet-induced body weight gain and adiposity in female C57BL/6J mice. Metabolism 53 (2004) 1284-1289
14. Kalderon B., Hertz R., and Bar-Tana J. Tissue selective modulation of redox and phosphate potentials by beta, beta′-methyl-substituted hexadecanedioic acid. Endocrinology 131 (1991) 1629-1635
15. Kersten S., Desvergne B., and Wahli W. Roles of PPARs in health and disease. Nature 405 (2000) 421-424
16. Kroetz D.L., Yook P., Costet P., Bianchi P., and Pineau T. Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes. The Journal of Biological Chemistry 273 (1998) 31581-31589
17. Lupien P., Brun D., Gagne C., Moorjani S., Bielman P., and Julien P. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins. The Canadian Journal of Cardiology 7 (1991) 27-33
18. Mancini F.P., Lanni A., Sabatino L., Moreno M., Giannino A., Contaldo F., Colantuoni V., and Goglia F. Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats. FEBS Letters 491 (2001) 154-158
19. Miyahara C., Miyazawa M., Satoh S., Sakai A., and Mizusaki S. Inhibitory effects of mulberry leaf extract on postprandial hyperglycemia in normal rats. Journal of Nutritional Science and Vitaminology (Tokyo) 50 (2004) 161-164
20. Oh K.S., Kim M., Lee J., Kim M.J., Nam Y.S., Ham J.E., Shin S.S., Lee C.M., and Yoon M. Liver PPARα and UCP2 are involved in the regulation of obesity and lipid metabolism by swim training in genetically obese db/db mice. Biochemical and Biophysical Research Communications 345 (2006) 1232-1239
21. Oku T., Yamada M., Nakamura M., Sadamori N., and Nakamura S. Inhibitory effects of extractives from leaves of Morus alba on human and rat small intestinal disaccharidase activity. The British Journal of Nutrition 95 (2006) 933-938
22. Pan J., Liu G., Liu H., Qiu Z., and Chen L. Effects of Artemisia capillaris on blood glucose and lipid in mice. Zhong Yao Cai 21 (1998) 408-411
23. Rustan A.C., Christiansen E.N., and Drevor C.A. Serum lipids, hepatic glycerolipid metabolism and peroxisomal fatty acid oxidation in rats fed omega-3 and omega-6 fatty acids. The Biochemical Journal 283 (1992) 333-339
24. Schoonjans K., Staels B., and Auwerx J. Role of peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. Journal of Lipid Research 37 (2000) 907-925
25. Sharpe P.A., Blanck H.M., Williams J.E., Ainsworth B.E., and Conway J.M. Use of complementary and alternative medicine for weight control in the United States. Journal of Alternative and Complementary Medicine (New York, NY) 13 (2007) 217-222
26. Sinal C.J., Yoon M., and Gonzalez F.J. Antagonism of the actions of peroxisome proliferator-activated receptor-α by bile acids. Journal of Biological Chemistry 276 (2001) 47154-47162
27. Skrede S., Sorensen H.N., Larsen L.N., Steineger H.H., Hovik K., Spydevold O.S., Horn R., and Bremer J. Thia fatty acids, metabolism and metabolic effects. Biochimica et Biophysica Acta 1344 (1997) 115-131
28. Son C.G., Choi W.J., Shin J.W., Han S.H., Cho J.H., Song K.C., and Cho C.K. Effects of gamichunggantang on hyperlipidemia. Acta Pharmacologica Sinica 24 (2003) 133-139
29. Staels B., Dallongeville J., Auwerx J., Schoonjans K., Leitersdorf E., and Fruchart J.C. Mechanism of action of fibrate on lipid and lipoprotein metabolism. Circulation 98 (1998) 2088-2093
30. Valcheva-Kuzmanova S., Kuzmanov K., Tancheva S., and Belcheva A. Hypoglycemic and hypolipidemic effects of Aronia melanocarpa fruit juice in streptozotocin-induced diabetic rats. Methods and Findings in Experimental and Clinical Pharmacology 29 (2007) 101-105
31. Yan Z.H., Karam W.G., Staudinger J.L., Medvedev A., Ghanayem B.I., and Jetten A.M. Regulation of peroxisome proliferator-activated receptor alpha-induced transactivation by the nuclear orphan receptor TAK1/TR4. The Journal of Biological Chemistry 273 (1998) 10948-10957
32. Yoon M., Jeong S., Nicol C.J., Lee H., Han M., Kim J.J., Seo Y.J., Ryu C., and Oh G.T. Fenofibrate regulates obesity and lipid metabolism with sexual dimorphism. Experimental and Molecular Medicine 34 (2002) 485-492
33. Yoon M., Jeong S., Lee H., Han M., Kang J.H., Kim E.Y., Kim M., and Oh G.T. Fenofibrate improves lipid metabolism and obesity in ovariectomized LDL receptor-null mice. Biochemical and Biophysical Research Communications 302 (2003) 29-34